Trial Results of Superoxide Dismotase Mimetic GC4419 to Reduce Chemoradiotherapy-induced Oral Mucositis #hncs16

Trial Results of Superoxide Dismotase Mimetic GC4419 to Reduce Chemoradiotherapy-induced Oral Mucositis #hncs16

ASTROHN2016

3 years
362 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Carryn Anderson, MD of the University of Iowa Carver College of Medicine discusses the trial results of Superoxide Dismotase Mimetic GC4419 to Reduce Chemoradiotherapy-induced Oral Mucositis at ASTRO Head and Neck Symposium 2016.
Up Next Autoplay
2019 Nobel Prize for Medicine Recipients recognized for Cancer Research  through study of von Hippel-Lindau (VHL) disease
2019 Nobel Prize for Medicine Recipients recognized for Cancer Research through study of von Hippel-Lindau (VHL) disease
Category: Acute Lymphoblastic Leukemia
4 Views
Cancer-News 6 days
INNATE PHARMA HIGHLIGHTS FDA-APPROVED LUMOXITI® AT ASH 2019
INNATE PHARMA HIGHLIGHTS FDA-APPROVED LUMOXITI® AT ASH 2019
Category: Acute Lymphoblastic Leukemia
7 Views
Cancer-News 6 days
Phase 1/2 AUGMENT-101 Trial @sloan_kettering
Phase 1/2 AUGMENT-101 Trial @sloan_kettering
Category: Acute Lymphoblastic Leukemia
13 Views
Memorial Sloan Kettering 3 weeks
Melanoma Rates Decline Found in Younger Population
Melanoma Rates Decline Found in Younger Population
Category: Acute Lymphoblastic Leukemia
2 Views
Cancer-News 1 month
Syndax Announces First Patient Dosed in Phase 1/2 AUGMENT-101 Trial of SNDX-5613 for the Treatment of Adults with Relapsed/Refractory Acute Leukemias
Syndax Announces First Patient Dosed in Phase 1/2 AUGMENT-101 Trial of SNDX-5613 for the Treatment of Adults with Relapsed/Refractory Acute Leukemias
Category: Acute Lymphoblastic Leukemia
12 Views
Cancer-News 1 month
What is PFS2 in Advanced NSCLC, and Should we Care_ Unique Analysis of the KEYNOTE-024 trial [720p] - OncologyTube
What is PFS2 in Advanced NSCLC, and Should we Care_ Unique Analysis of the KEYNOTE-024 trial [720p] - OncologyTube
Category: Acute Lymphoblastic Leukemia
38 Views
Stan 3 months
Patient Priorities Should be Paramount when Measuring Quality in Cancer Care According to Panelists at NCCN Policy Summit
Patient Priorities Should be Paramount when Measuring Quality in Cancer Care According to Panelists at NCCN Policy Summit
Category: Acute Lymphoblastic Leukemia
23 Views
Cancer-News 3 months
IASLC World Conference on Lung Cancer—Press Briefing Summary from Sunday, September 8th in Barcelona
IASLC World Conference on Lung Cancer—Press Briefing Summary from Sunday, September 8th in Barcelona
Category: Acute Lymphoblastic Leukemia
33 Views
Cancer-News 3 months
IPS based approach for treating virus-induced tumors
IPS based approach for treating virus-induced tumors
Category: Acute Lymphoblastic Leukemia
12 Views
Cancer-News 3 months
Pivotal New Data from Merck’s Broad Oncology Portfolio at ESMO 2019 Congress
Pivotal New Data from Merck’s Broad Oncology Portfolio at ESMO 2019 Congress
Category: Acute Lymphoblastic Leukemia
54 Views
Cancer-News 3 months